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Summary
Sulfatases are enzymes essential for degradation and
remodeling of sulfate esters. Formylglycine (FGly),
the key catalytic residue in the active site, is unique
to sulfatases. In higher eukaryotes, FGly is generated
from a cysteine precursor by the FGly-generating en-
zyme (FGE). Inactivity of FGE results in multiple sulfa-
tase deficiency (MSD), a fatal autosomal recessive
syndrome. Based on the crystal structure, we report
that FGE is a single-domain monomer with a surpris-
ing paucity of secondary structure and adopts a
unique fold. The effect of all 18 missense mutations
found in MSD patients is explained by the FGE struc-
ture, providing a molecular basis of MSD. The cata-
lytic mechanism of FGly generation was elucidated
by six high-resolution structures of FGE in different
redox environments. The structures allow formulation
of a novel oxygenase mechanism whereby FGE uti-
lizes molecular oxygen to generate FGly via a cys-
teine sulfenic acid intermediate.
Introduction
Enzymes of the sulfatase family mediate hydrolysis of
sulfate esters such as glycosaminoglycans, sulfolipids,
and steroid sulfates in eukaryotic cells. Reduced activ-
ity of sulfatases is linked to severe lysosomal storage
disorders such as mucopolysaccharidoses and met-
achromatic leukodystrophy and to nonlysosomal disor-
ders such as X-linked ichthyosis and chondrodysplasia
punctata (Hopwood and Ballabio, 2001). Causative
mechanisms for these diseases include missorting of
sulfatases and mutations in sulfatase-encoding genes
that lead to inactive enzymes. However, a severe reduc-
tion or complete lack of all sulfatase activities, termed
multiple sulfatase deficiency (MSD), originates from
mutations in the gene coding for FGE, the formylglycine
(FGly)-generating enzyme (Cosma et al., 2003; Dierks et
al., 2003). Biochemical data (Dierks et al., 1997; Dierks et*Correspondence: kfigura@gwdg.de (K.v.F.); markus.rudolph@bio.
uni-goettingen.de (M.G.R.)
3 Present address: Department of Biochemistry I, University of Bie-
lefeld, D-33615 Bielefeld, Germany.al., 1998a; Dierks et al., 1998b; Miech et al., 1998;
Schmidt et al., 1995; Selmer et al., 1996; Szameit et al.,
1999) and crystal structures of human (Bond et al.,
1997; Hernandez-Guzman et al., 2003; Lukatela et
al., 1998) and bacterial (Boltes et al., 2001) sulfatases
revealed a unique FGly residue in the active site to be
essential for sulfate ester hydrolysis. Thus, inactive
FGE leads to lack of or incomplete generation of the
FGly residue in all 13 human sulfatases described to
date (Ferrante et al., 2002; Hopwood and Ballabio,
2001; Morimoto-Tomita et al., 2002), with its pathologi-
cal manifestations.
FGE is localized in the endoplasmic reticulum (ER)
and interacts with and modifies the unfolded form of
newly synthesized sulfatases (Dierks et al., 1997; Dierks
et al., 1998a). In the folded sulfatase, FGly is buried in
a deep cleft and is inaccessible to FGE (Boltes et al.,
2001; Lukatela et al., 1998). Also present in the ER is
the FGE paralog pFGE, which shares 50.6% sequence
identity (57.4% homology) with FGE over 283 residues.
The function of pFGE is ill defined at present, as it pos-
sesses no FGly-generating activity. However, the pFGE
gene expression levels are substantial and the pFGE/
FGE ratios are approximately equal in all tissue types
studied, pointing to a function of pFGE that is related
to FGE activity (Mariappan et al., 2005).
The generation of FGly from a cysteine residue is a
multistep redox process that involves disulfide bond
formation and requires calcium, molecular oxygen, and
a reducing agent (Fey et al., 2001; J. Peng, K.v.F., T.D.,
B.S., A.P.-K., and M.M., unpublished). This process has
been reconstituted in vitro by use of sulfatase-derived
peptides as substrates and DTT as the reducing agent
(Dierks et al., 2003; Preusser-Kunze et al., 2005). Com-
parison of FGE sequences from different higher eukary-
otes and mass spectrometric analyses revealed six
conserved cysteine residues that are organized in three
disulfide bonds, one of which is partially reduced and
may participate in FGly formation. Notably, no redox-
active metal ion or any cofactor is required for FGE ac-
tivity, and molecular oxygen serves as the terminal
electron acceptor. The details of how oxygen-depen-
dent cysteine oxidation is mediated in the ER in general
remains unclear, despite the crystal structures of two
cysteine oxigenases involved in protein disulfide forma-
tion, Ero1p and Erv2p (Gross et al., 2002; Gross et al.,
2004).
We determined the crystal structure of FGE to delin-
eate the active site and extract a structure-based
mechanism for FGly generation. FGE is a single-domain
monomer with a surprising paucity of secondary struc-
ture and adopts a unique fold that is stabilized by two
Ca2+ ions. The effect of all mutations found in MSD pa-
tients is explained by the FGE structure, providing a
molecular basis for MSD. A redox-active disulfide bond
is present in the active site of FGE. Most strikingly, an
oxidized cysteine residue, possibly cysteine sulfenic
acid, was detected that allows formulation of a struc-
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542ture-based mechanism for FGly formation from cys-
teine residues in all sulfatases.
Results and Discussion
Overall FGE Structure
Six independent structures were determined from crys-
tals grown in different redox environments by molecular
replacement using pFGE (Dickmanns et al., 2005) as a
search model and refined to resolutions between 2.6 Å
and 1.55 Å with excellent stereochemistry (Table 1).
Main features of the FGE structure include the pres-
ence of two Ca2+ ions, N-glycosylation at Asn141, two
cis-peptide bonds at Pro115 and Pro266, and three di-
sulfide bonds (Figure 1A). FGE is a compact molecule
without obvious domain boundaries that have been
suggested from sequence comparisons (Landgrebe et
al., 2003) and proteolytic experiments (Preusser-Kunze
et al., 2005). The protein adopts a novel fold (Figure 1B)
that is similar to pFGE (Dickmanns et al., 2005) but also
displays important differences. The secondary struc-
ture content of FGE is low with only 20% β- and 13%
α-structure. 3% of all residues adopt a 310-helical con-
formation. β strands β7, β8, β10, β13, and β14 are very
short, consisting of only two residues. No structural ho-
mologs were found in the DALI database (Holm and
Sander, 1993), which puts FGE and pFGE into a new
family of proteins adopting an “FGE” fold. The presence
of a novel fold testifies to the unique function of FGE
and supports the possibility that FGE and pFGE may
have evolved from a common ancestor (Landgrebe et
al., 2003).
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rTable 1. Data Collection and Refinement Statistics
2: 1Y1I— 3: 1Y1F—SS/ 4: 1Y1H—SS/ 5: 1Y1J—SO3−/
Data Set # 1: 1Y1E—SS/SH reduced Cso Peo Ala 6: 1Y1G—2×SO3−
Data Collection 29.8–1.73 31.4–2.58 29.8–1.80 29.9–1.67 41.1–1.55 29.8–1.67
Resolution range (Å)a (1.78–1.73) (2.67–2.58) (1.86–1.80) (1.72–1.66) (1.61–1.55) (1.73–1.67)
Measured reflections 89,457 (5,194) 22,390 (156) 108,643 (1,320) 115,895 (1,934) 91,746 (1,024) 240,190 (12,805)
Unique reflections 30,898 (2,243) 7,791 (133) 25,226 (891) 32,268 (1,167) 35,522 (820) 34,756 (3,182)
Multiplicity 2.9 (2.3) 2.9 (1.2) 4.3 (1.5) 3.6 (1.7) 2.6 (1.25) 6.9 (4.0)
Completeness (%) 97.0 (72.2) 79.9 (14.0) 89.7 (32.5) 89.8 (32.9) 80.7 (19.1) 99.3 (93.1)
Mosaicity (º) 1.20 0.86 0.55 0.48 0.63 0.59
Rsym (%)b 6.3 (26.4) 14.0 (31.1) 7.6 (19.1) 4.9 (13.1) 4.3 (16.2) 5.5 (28.8)
Average I/σ(I) 17.3 (1.6) 6.3 (1.5) 23.2 (3.5) 32.5 (4.5) 26.5 (3.3) 41.1 (4.5)
Refinement 29.8–1.73 31.4–2.61 29.8–1.8 29.9–1.67 41.1–1.55 29.8–1.67
Resolution range (Å) (1.78–1.73) (2.67–2.61) (1.85–1.80) (1.71–1.67) (1.59–1.55) (1.71–1.67)
Rcryst (%)c 19.4 (27.6) 15.0 (24.5) 14.8 (19.4) 14.6 (19.2) 15.8 (27.6) 14.6 (21.0)
Rfree (%)c 24.2 (34.2) 25.2 (37.6) 19.4 (27.0) 17.6 (26.1) 19.3 (24.3) 17.6 (28.3)
# of residues/waters 272/407 275/255 272/429 275/473 276/471 275/426
Coordinate error (Å)d 0.102 0.252 0.071 0.049 0.054 0.052
Rms bonds (Å)/ 0.010/1.36 0.017/1.67 0.013/1.41 0.010/1.33 0.010/1.34 0.010/1.27
angles (º)
Ramachandran plot 88.3/10.8/0/0.9 86.2/12.9/0/0.9 89.2/9.9/0/0.9 87.9/11.2/0/0.9 88.4/10.7/0/0.9 87.9/10.7/0.4/0.9
(%)e
Average B values (Å2) 29.4 ± 7.6 30.2 ± 7.5 16.3 ± 9.2 19.5 ± 9.6 17.5 ± 9.1 25.7 ± 9.4
a Values in parentheses correspond to the highest resolution shell.
b Rsym = 100·ΣhΣi|Ii(h) − <I(h)>|/ΣhΣiIi(h), where Ii(h) is the ith measurement of reflection h and <I(h)> is the average value of the reflection intensity.
c Rcryst = 100·Σ|Fo| − |Fc|/Σ|Fo|, where Fo and Fc are the structure factor amplitudes from the data and the model, respectively. Rfree is Rcryst
with 5% of test set structure factors.
d Based on maximum likelihood.
e Calculated using PROCHECK (Laskowski et al., 1993). Numbers reflect the percentage amino acid residues in the core, allowed, generous
allowed, and disallowed regions, respectively.omparison of FGE and pFGE
GE and pFGE are the first structurally characterized
embers of a large protein family registered as DUF323
domain of unknown function 323) in the PFAM data-
ase of protein families (Bateman et al., 2000). This
amily currently comprises 168 prokaryotic and eukary-
tic proteins of very different functions, including xyla-
ase, transcriptional regulators, and nitrate reductors.
ased on the average sequence similarity of 25%, it
as been concluded that all members of this family
dopt an FGE fold (Dickmanns et al., 2005). However,
ven the close paralogs FGE and pFGE differ signifi-
antly already at the sequence level, suggesting
xtensive structural variation within this protein family.
his prompted us to more elaborately compare the FGE
nd pFGE structures.
FGE and pFGE superimpose closely with a root mean
quare deviation of 1.07 Å over 240 Cα atoms. There
re three larger insertions in the FGE sequence relative
o pFGE, which map to two loop regions (Figure 2A).
he first insertion of three residues in FGE immediately
recedes the N-glycosylation site of pFGE. The second
nd third insertions mark an increased loop length of
2 residues from Asp304-Lys325 in FGE as opposed to
our residues from Ala244-Gln247 in pFGE. Interest-
ngly, a short β strand (β10) is formed by the larger loop
n FGE that extends the β sheet β2/β3 present in pFGE
Figures 1 and 2A, right). The insertions are remote from
he active site (see below) but conserved among all
GEs, suggesting an important function that is both un-
elated to FGly formation and lacking in pFGEs.
Of the complex glycosylation present in FGE (Preus-
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543Figure 1. Structure Sequence Relationship of FGE
(A) Structure-based sequence alignment of human FGE and pFGE. The secondary structure elements (η denotes a 310-helix) for FGE are
shown above the sequence. Conserved and homologous residues are colored blue and shown as bold and normal typeface, respectively.
The sequence region Ser163-Ala176 (dashed underscored) was removed from FGE by elastase treatment. The disulfide-forming cysteine
residues are boxed pairwise in red (active site), orange, and yellow (conserved in pFGE). Green boxes indicate the single N-glycosylation
sites in FGE and pFGE. Two cis-prolines are conserved between FGE and pFGE and indicated by black underscores and labeled “cis.” Ca2+
binding residues share a cyan (site 1) and magenta (site 2) background. The sequence domains assigned on the basis of phylogenetic
conservation (Landgrebe et al., 2003) are boxed in cyan, magenta, and green.
(B) Stereo diagram of FGE with the secondary structure elements indicated and the sequence domains colored as in (A). The Ca2+ ions are
drawn as spheres in cyan (site 1) and magenta (site 2). The missing loop region is indicated as a dashed line.ser-Kunze et al., 2005), the two proximal N-acetyl-glu-
cosamine residues were identified from the electron
density maps at Asn141. While many FGEs, including
the enzymes from mouse, rat, chicken, pig, and trout,
conserve the glycosylation site, this site is missing in
FGE from toad, frog, medaka, and pufferfish. By con-trast, all known pFGEs but the one from sea urchin con-
serve a glycosylation site at Asn191, putting the carbo-
hydrate at the other end of the molecule (distance
35 Å; Figure 2A).
Two metal ions, buried in the hydrophobic core, were
clearly identified in the electron density maps of FGE.
Cell
544Figure 2. Comparison of FGE and pFGE
(A) Superposition of FGE and pFGE. pFGE is
shown as a gray ribbon representation,
whereas for FGE α helices are colored red, β
strands blue, and loop regions yellow. The
two Ca2+ ions in pFGE are drawn in gray, and
the Ca2+ ions in FGE are shown as transpar-
ent spheres in cyan (site 1) and magenta (site
2). The three insert regions in FGE relative to
pFGE are labeled and shown in green. The
carbohydrate moieties are located on oppo-
site sides of the molecules and are drawn as
stick models.
(B) Stereochemistry of Ca2+ binding site 2 in
pFGE (left) and FGE (right). The side chain of
pFGE Leu230 is truncated at Cβ for clarity.
(C) Effect of the absence of the second disul-
fide bond in pFGE (left) compared to FGE
(right). The σA-weighted mFo − DFc omit
electron density map around the disulfide
bond is contoured at 3σ.The chemical nature of these ions was determined as
Ca2+ by analysis of their coordination sphere and by
anomalous difference Fourier maps calculated from a
data set of high multiplicity (not shown). In addition, the
crystallization conditions included >0.2 M CaCl2, ensur-
ing full occupancy of the Ca2+ sites. Although K+ is an-
other candidate ion for the observed binding geome-
tries and the Fourier analyses, given the much higher
concentration of Ca2+ compared to K+ in the ER, any
significant binding of K+ to FGE in vivo seems unlikely,
and Ca2+ will be the natural ligand for FGE. This conclu-
sion is also supported by plasma mass spectroscopic
results (see below). Two similarly located Ca2+ ions
have been identified in pFGE (Dickmanns et al., 2005),
which is also retained in the ER. The Ca2+ ion at site 1
in FGE is 7-fold coordinated by a bidentate interaction
with the Asp273 side chain, the Asn259 side chain, the
carbonyl groups of Ile260 and Phe275, and two water
molecules. The coordination geometry can best be de-
scribed as a distorted pentagonal bipyramid and is
conserved in pFGE. In pFGE, Ca2+ site 2 is coordinated
in an irregular fashion by the side chain of Glu236, the
carbonyl groups of Asp229, Leu230, Gly232, and
Val234, and one water molecule (Figure 2B, left). This
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oon binding site differs drastically in FGE because of
he presence of a new ligand, Glu130, instead of the
ro68 present in pFGE. The Glu130 side chain replaces
he water molecule and shifts the Ca2+ ion by 0.85 Å
elative to its position in pFGE. This abolishes the in-
eraction with the carbonyl group of Leu230, and a
ater molecule occupies the free coordination site. The
et result is an almost perfect octahedral coordination
f Ca2+ in FGE by the side chains of Glu130 and Glu300,
he carbonyl groups of Asn293, Gly296, and Ala298,
nd a water molecule (Figure 2B, right). As Glu130 is
onserved in all FGE sequences and, likewise, Pro68 is
onserved in all pFGE sequences, it can be concluded
hat the Ca2+ geometry at site 2 will be the same for all
GEs and pFGEs and exhibit the same differences
hen FGEs and pFGEs are compared. In summary, the
a2+-coordinating residues are conserved in most FGE
equences, suggesting that the two Ca2+ ions are an
ntegral part of FGE/pFGE protein stability.
The observation that pFGE crystallizes as a dimer in
he asymmetric unit (Dickmanns et al., 2005) and, more
ompellingly, that FGE/pFGE expression levels are sim-
lar throughout different tissue types and that pFGE
verproduction antagonizes FGE activity (Mariappan et
Structure of Human Formylglycine-Generating Enzyme
545al., 2005) suggests the possibility that FGE may form
heterodimers with pFGE. In solution, no heterodimers
were observed by gel permeation chromatography
(data not shown), establishing that the affinity of FGE
for pFGE, if present, is low. FGE/pFGE dimers are steri-
cally possible, albeit with a small buried surface area
and a low surface complementarity (Dickmanns et al.,
2005). While these considerations suggest such a di-
mer to be unstable, they do not rule out a possible in-
teraction of FGE and pFGE in the presence of sulfa-
tases. If FGE/pFGE heterodimerization cannot explain
the antagonistic effect of pFGE on FGE activity (Mari-
appan et al., 2005), another unidentified protein with a
function that links pFGE to FGE activity may be in-
volved.
Two out of three disulfide bonds, Cys218-Cys365 and
Cys235-Cys346, are permanently present in FGE and
contribute to its stability. The Cys218-Cys365 disulfide
bond is also present in pFGE and adopts the same
structure, establishing its role in protein stabilization.
Ala173 and Val271 in pFGE (Figure 2C, left) replace the
second disulfide bond in FGE (orange in Figures 1 and
2C, right). Ala173 is conserved among all pFGEs while
position 271 can be either valine or isoleucine (sea
urchin and trout). The lack of the second disulfide bond
in pFGE leads to a rigid body shift of the region Ala269-
Thr273 by about 1.8 Å away from Ala173 toward the
surface, with a concomitant expansion of the whole
pFGE structure. The third disulfide bond in FGE,
Cys336-Cys341, has varying occupancies in the FGE
crystal structures and participates in catalysis (see
below).
Delineation of the Substrate Binding
and Active Sites
Cysteine-containing peptides generated from human
sulfatases have proven invaluable for an in vitro assay
of FGE activity (Dierks et al., 2003). A 23-mer peptide
derived from arylsulfatase A, ASA p23-Bpa77, compris-
ing ASA residues 60-TDFYVPVSLCTPSRAALBpaTGR-
80 (the modified Cys69 residue is bold, the minimal mo-
tif for modification is underlined), which carries the
photoreactive p-benzoyl-phenylalanine (Bpa) at posi-
tion Leu77, crosslinks to Pro182 in FGE (Preusser-
Kunze et al., 2005).
Mixed disulfide bonds between a substrate peptide
and preferentially Cys341, and to a much lesser extent
also with Cys336, were observed by mass spectrome-
try (J. Peng, K.v.F., T.D., B.S., A.P.-K., and M.M., unpub-
lished). In addition, Cys336 and Cys341 are conserved
among all FGEs and are in close proximity to each
other, facilitating intramolecular disulfide bond forma-
tion. The loop between Cys336/Cys341 displays ele-
vated main chain temperature factors, suggesting
structural flexibility, which is a hallmark for regions un-
dergoing conformational changes during binding events
(Luan et al., 2000). Thus, the redox-active Cys336/Cys341
region in FGE is a prime candidate for a catalytic entity.
The active site, therefore, is likely to comprise all three
residues: Pro182, Cys336, and Cys341.
The distance between the Cα atoms of Cys341 and
Pro182 is w21 Å. For a fully extended conformation,
the distance between Cys69 and Leu77 in the ASA p23peptide is calculated to 27 Å. Thus, the substrate pep-
tide could easily span the distance between Cys341
and Pro182, and the distances involved suggest that
the substrate is bound to FGE in an almost completely
extended fashion. No crosslinks were detected with
peptides that carried the photoactive Bpa label N-ter-
minal to the modified Cys69 (Preusser-Kunze et al.,
2005), further establishing that the orientation of the
substrate with respect to FGE is not arbitrary but with
the N-terminal part at Cys341 and the C-terminal part
located in the vicinity of Pro182.
Indeed, a surface representation of FGE shows an
oval-shaped groove of 20 Å length, 10 Å depth, and 12 Å
width (yellow in Figure 3) that is bordered by the
Cys336/Cys341 pair at one end and Pro182 at the other
end. This groove is sufficiently large to host up to six
amino acids of a substrate and thus could accommo-
date the minimal sequence motif of CXPSR (where X is
T, S, C, or A) that can be converted to FGly by FGE.
Eleven residues (Ala149, Ser155, Trp299, Lys329,
Ser333, Met335, Ser356, Ser357, Ala358, Asn360, and
Leu361) line the groove. Importantly, the groove is ex-
tended in both directions, although not as deep, along
the surface of FGE, which enlarges the substrate bind-
ing area. Asn107, Arg338, and Tyr342 (magenta in Fig-
ure 3) at the N-terminal substrate binding site and
Phe152 and Asn154 (blue in Figure 3) at the C-terminal
substrate binding site form these areas. In conclusion,
the “channel” across the surface of FGE and the groove
bordered by the reactive disulfide bond and Pro182 in
FGE constitute a functionally bipartite binding/active
site for the unfolded sulfatase substrates.
Cys336/Cys341 Is a Redox-Active Disulfide Bond
and Essential for Catalysis
We assessed the redox activity of the Cys336/Cys341
pair and its role in the catalytic mechanism of FGE by
six independent crystal structures, which were deter-
mined from crystals of different age or that were grown
under different redox environments. Unlike all other
cysteine residues in FGE, Cys336 and Cys341 are ex-
tremely sensitive to oxidation. In structure 1 (Figure 4A),
obtained from a 3-day-old crystal, the Cys336/Cys341
pair is oxidized and reduced, respectively, in about half
of the molecules. A fully reduced FGE molecule was
generated by addition of 20 mM cysteine to the crystal-
lization setup (structure 2; Figure 4B). Older FGE crys-
tals of 16 days (structure 3; Figure 4C) and 39 days
(structure 4; Figure 4D) clearly show the presence of a
partial Cys336-Cys341 disulfide bond. Surprisingly, ad-
ditional unbiased Fo − Fc electron density is visible in
both structures at the part of Cys336 that is not en-
gaged in a disulfide bond. This density is fitted equally
well by a cysteine sulfenic acid plus a water molecule
that is partially occupied (Cys-S-OH or Cso; Figure 4C)
or by a hydroperoxide moiety (Cys-S-O-OH or Peo; Fig-
ure 4D). Both of these entities may represent catalyti-
cally relevant intermediates, although the peroxide moi-
ety presumably is less stable than the sulfenic acid. The
sensitivity of the Cys336/Cys341 pair to oxidation is fur-
ther borne out by a structure determined from a 22-
day-old FGE crystal grown at pH 10.5. This structure
shows Cys336 to be oxidized to cysteine sulfonic acid
Cell
546Figure 3. Substrate Binding Groove in FGE
(A) The surface representation of FGE shows
a groove stretching from the site of the
crosslink at Pro182 to the redox-active cys-
teine pair Cys336/Cys341. The solvent-
accessible surfaces of Pro182 and the cys-
teine residues are colored green and red, re-
spectively. The surfaces of residues forming
the deep groove are colored in yellow. Ma-
genta and blue surfaces mark the areas that
bind to parts of the substrate that are N- and
C-terminal to the modified cysteine residue.
(B) Side view and close-up of (A).Cys336/Cys341 pair. Oxidation of cysteine to the sul-
Figure 4. Structural Plasticity of the Active
Site Cysteine Residues in FGE Crystal Struc-
tures from Different Redox Environments
(A) Cys336 forms a partial disulfide bond
with Cys341 in this structure. The other con-
formation of Cys336 hydrogen bonds to a
water molecule, which is also bound by
Ser333 (structure 1).
(B) The reduced form of the Cys336/Cys341
pair (structure 2). The distance of the two
sulfur atoms is 3.4 Å, which is too far for a
disulfide bond (2.03 Å).
(C) Two conformers of the Cys336/Cys341
pair. Cys336 either forms a disulfide bond
with Cys341 or is oxidized to the sulfenic
acid (structure 3).
(D) Very similar electron density is present at
Cys336 in another structure from a crystal
grown in the presence of SrCl2 instead of
CaCl2 (structure 4). Cysteine peroxide is an
alternative description of this electron
density.
(E) Electron density of the Cys336/Cys341
region from a structure determined at pH
10.5 (structure 5). Cys336 is oxidized to the
sulfonic acid, while Cys341 has no electron
density beyond Cβ.
(F) A different oxidation pattern of the same
region produced by 0.5% H2O2 during crys-
tallization (structure 6). Both cysteine resi-
dues are converted to the sulfonic acids. The
bulky sulfonic acid at position 341 forces the
Tyr340 side chain to reorient toward the
solvent. All σA-weighted mFo − DFc omit
electron density maps are contoured at the
4σ level.
mutant proteins as compared to the wild-type control(structure 5; Figure 4E). No electron density is visible
for Cys341 beyond Cβ, suggesting either rotational dis-
order or desulfuration to alanine. Likewise, addition of
0.5% H2O2 to the crystallization setup resulted in com-
plete oxidation of both cysteine residues to the sulfonic
acids within % 13 days (structure 6; Figure 4F). Oxida-
tion to cysteine sulfonic acid is irreversible, thus elimi-
nating it as an intermediate. But given the fact that the
other disulfide bonds do not show any signs of oxida-
tion as opposed to complete oxidation of the Cys336/
Cys341 pair, it can be concluded that the redox chemis-
try during FGly formation must be carried out at the
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lonic acid is irreversible, leading to a dead-end side
roduct. This raises the problem of FGE inactivation in
he ER by reactive oxygen species that are generated
uring oxidative protein folding (Tu et al., 2000).
The direct implication of Cys336 and Cys341 in FGE
atalysis was proven by the inactivity of the serine mu-
ants. The C336S and C341S FGE proteins were puri-
ied to homogeneity from stably overproducing HT1080
utant cell lines and analyzed for FGly-generating ac-
ivity in vitro. Both mutants are catalytically inactive
<0.2% of wild-type activity). Even extensively pro-
onged incubation times and using 50-fold more of the
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547did not result in detectable substrate turnover. These
data demonstrate that both Cys336 and Cys341 are
part of the active site and essential for the FGly-gener-
ating activity of FGE.
FGE Employs a Nonclassical Mechanism
for Cys Oxidation
Many enzymes catalyzing redox processes use redox-
active metals in Fe-S- or Mo-Fe-clusters, or Ni2+ or
Cu2+ to exchange electrons during catalysis. Others rely
on nucleotide or protein cofactors such as NAD(P)+, FAD,
or the thioredoxins, which employ reversible disulfide
bond formation during catalysis. The ER-localized oxi-
dase Ero1p reoxidizes protein disulfide isomerase by a
flavin-dependent mechanism with molecular oxygen as
the terminal electron acceptor (Gross et al., 2004; Tu et
al., 2000). Examples of metal ion-containing oxidases
located in the ER include the Cu-dependent monooxi-
genase X (Xin et al., 2004) and the Fe-dependent dioxi-
genase prolyl 3-hydroxylase 1 (Vranka et al., 2004).
Thus, it seemed possible that FGE could employ either
of these or a similar strategy for catalysis.
As organic cofactors neither are needed for catalysis
nor are present in the FGE electron density maps, in-
volvement of flavines or nicotinamides, for example,
can be ruled out. A thioredoxin-type mechanism seems
unlikely because thioredoxins rely on accessory pro-
teins for reoxidation of their disulfide bond, whereas
FGE displays multiturnover catalysis independent of
other protein factors (J. Peng, K.v.F., T.D., B.S., A.P.-K.,
and M.M., unpublished). Initially, the finding of two
metal ions in the FGE electron density maps raised the
question of whether they partake in the mechanism.
Metal ion catalysis is essential for FGly generation in
prokaryotes such as K. pneumoniae, where the FGE an-
alog AtsB uses a Fe-S-cluster to convert a serine resi-
due in the periplasmic sulfatase AtsA to FGly (Fang et
al., 2004; Marquordt et al., 2003). However, in FGE sev-
eral lines of evidence argue against metal ion involve-
ment in catalysis. First, no requirement of a redox-
active metal ion was found in in vitro assays. Second,
plasma mass spectrometry established molar ratios
Ca2+/FGE and K+/FGE of 1.65 and 0.69, respectively,
without significant content of redox-active metals (Pre-
usser-Kunze et al., 2005). Third, redox-active metal ions
such as Cu2+ in coupredoxins and Fe2+ in dioxigenases
are often bound to at least one cysteine or histidine
residue, respectively (Karlin et al., 1997), which is not
the case in FGE. Where Ca2+ is present in other redox-
active proteins such as horseradish peroxidase (Haschke
and Friedhoff, 1978), lignin peroxidase (Poulos et al.,
1993), and the di-heme Paracoccus cytochrome c per-
oxidase (Gilmour et al., 1994), it was always found to
serve a structural, not a catalytic, purpose. In summary,
eukaryotic FGEs must employ a unique mechanism
that involves a disulfide bond and that is very different
from the redox chemistry seen in conventional oxigen-
ases and dehydrogenases.
The Catalytic Cycle of FGly Generation
Formally, the oxidation of an alcohol or a thiol to the
respective aldehyde requires abstraction of a hydride
ion from the carbon atom carrying the hydroxyl or thiylgroup. This strategy is used by NAD+-dependent dehy-
drogenases but cannot be employed by FGE due to the
absence of a hydride acceptor in the active site. An-
other strategy would be the oxidation of the thiol sulfur
atom to a sulfenic acid, followed by a β-elimination of
hydroxide or water. In the case of a cysteine residue,
this elimination requires abstraction of a proton from
the Cβ-atom by a catalytic base. This scenario is sup-
ported by the cysteine sulfenic acid at position 336 in
structure 3 (Figure 4C). Cys336 exhibits two alternate
conformations, either forming a disulfide bond with
Cys341 or existing as cysteine sulfenic acid. As the re-
dox potential in the ER is more oxidizing than that of
the cytosol, both the disulfide-bridged form of FGE and
the sulfenic acid are likely reaction intermediates in the
catalytic cycle.
Cysteine sulfenic acids are implicated in diverse cel-
lular processes, including signal transduction, tran-
scriptional regulation, oxygen metabolism, and the oxi-
dative stress response (Claiborne et al., 1999). In
enzymes, stable cysteine sulfenic acid moieties have
been found in NADH peroxidase (Yeh et al., 1996),
NADH oxidase (Ahmed and Claiborne, 1989), nitrile hy-
dratase, and the hORF6 (Choi et al., 1998) and AhpC
(Ellis and Poole, 1997) peroxiredoxins, where they
either are involved in substrate binding or take part in
catalysis. The presence of the sulfenic acid in FGE
raises the question as to how Cys336 is oxidized. Re-
cently, it has been shown that molecular oxygen is a
substrate for FGE and that the stoichiometry of O2 con-
sumption and FGly formation is close to 1 (J. Peng,
K.v.F., T.D., B.S., A.P.-K., and M.M., unpublished). Thus,
the cysteine sulfenic acid in FGE could be generated in
the ER by reaction of O2 with Cys336, possibly by a
radical mechanism. The putative hydroperoxide at
Cys336 in structure 4 may be a product of this reaction,
which may then decompose to the sulfenic acid. Apart
from the cases where the cysteines were irreversibly
oxidized to the sulfonic acids by H2O2 (Figure 4E), no
oxidation to a sulfenic, sulfinic, or sulfonic acid was
ever seen with Cys341. This fact points to Cys336 as
the major redox partner during FGly generation. In con-
junction with the mass spectrometric result that pep-
tides form mixed disulfide bonds preferentially with
Cys341, two specific functions may be assigned to the
catalytically active cysteines: Cys341 binds the sub-
strate and Cys336 oxidizes it.
Three conserved residues, Ser333, His337, and
Tyr340, are present in the vicinity of the Cys336/Cys341
pair and could serve as catalytic bases for the elimina-
tion reaction. Ser333 is the most likely candidate, as it
is located only 4.6 Å from the modified Cys336 and
7.7 Å from Cys341. The proximity of Ser333 and Cys336
is congruent with a stabilization of the Cys336 sulfenic
acid by Ser333 (3.0 Å distance between the oxygen
atoms) and the substrate-oxidizing function of Cys336.
Because at some stage the β-elimination of water from
the cysteine sulfenic acid requires abstraction of a pro-
ton from the Cβ of the substrate cysteine, Ser333 would
have to either exhibit a perturbed pKa value or become
deprotonated during catalysis. The negative charge of
the forming anion would be stabilized by a hydrogen
bond to the Nδ atom of the side chain of conserved
Asn360, which is only 3.4 Å away from the Ser333 hy-
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548droxyl group. Alternatively, a solvent hydroxide ion
could deprotonate Ser333 in a concerted fashion dur-
ing attack of Ser333 on the Cβ-proton of the substrate.
This mechanism of activation of the catalytic base is in
line with the alkaline (pH 9–10) optimum of FGE activity
(Fey et al., 2001) and, more importantly, the presence
of electron density for an oxygen atom (water or hy-
droxide) in structures 1–3, which hydrogen bonds to
Ser333 (Figures 4A–4C). The alternative catalytic bases
His337 and Tyr340 are w10 Å and 7 Å away from
Cys336, respectively, rendering their involvement in ca-
talysis less likely.
To test the possible roles of residues Ser333, His337,
and Tyr340 in the catalytic mechanism of FGE, four mu-
tants (Ser333Ala, Ser333Thr, His337Ala, and Tyr340Phe)
were generated and assayed for FGE activity (see Sup-
plemental Table S1 available with this article online).
While the Tyr340Phe mutation did not affect FGE activ-
ity significantly, the His337Ala mutation resulted in a
5-fold decrease of specific activity. The most dramatic
effect is, however, displayed by the Ser333Ala (inactive;
<0.5% of wild-type activity) and Ser333Thr (<0.8% of
wild-type activity) mutants. Thus, Ser333 must be
strongly involved in the FGE catalytic mechanism and
is the prime candidate for the catalytic base.
The biochemical and structural data can be integ-
rated into a novel, yet at this stage of the analysis hypo-
thetical, reaction mechanism of FGly formation (Figure
5). In this mechanism, the resting state of FGE is as-
sumed to be the oxidized form with the Cys336-Cys341
disulfide bond. The substrate, i.e., the unfolded sulfa-
tase, undergoes a disulfide exchange reaction to form
a mixed disulfide with Cys341. The free Cys336 is oxi-
dized to the sulfenic acid by molecular oxygen in a mo-
nooxigenase-like fashion that requires a reducing agent
(glutathione or thioredoxin in vivo, or DTT in vitro) and
produces a water molecule. The hydroxyl group of the
Cys336-OH sulfenic acid is transferred to the substrate
cysteine to form a sulfenic acid in the sulfatase. This
reaction is similar to a step in the proposed mechanism
for the N. gonorrhoeae pilB methionine sulfoxide reduc-
tase (Lowther et al., 2002) and regenerates the disulfide
bonded form of FGE. The catalytic base Ser333 initiates
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(1) Formation of the mixed disulfide intermediate between the substrate and Cys341 of FGE.
(2) Generation of the sulfenic acid at Cys336.
(3) Transfer of the hydroxyl group from Cys336 to the substrate cysteine residue and regeneration of the disulfide form of FGE.
(4) Attack of a catalytic base at Cβ of the substrate cysteine sulfenic acid and elimination of water/hydroxide.
(5) Spontaneous hydrolysis of the thioaldehyde intermediate to FGly. Alternative mechanisms with the cysteine sulfenic acid moiety solely in
the peptide are conceivable but do not accommodate the observed modification of Cys336. XH2 denotes the chemical (DTT) or biological
(e.g., glutathione) reducing agent.β-elimination of a good leaving group, the hydroxide
on, by abstraction of a proton from the Cβ-atom of the
ubstrate cysteine sulfenic acid. The product is a thio-
ldehyde, which is unstable under aqueous conditions
nd undergoes spontaneous hydrolysis to FGly and
2S. The net result is the conversion of one molecule
2 and a thiol into one molecule of water, H2S, and an
ldehyde (Figure 5).
This proposed FGly-generation mechanism raises
everal testable hypotheses. First, the product H2S
hould be identifiable by either radioactive labeling or
as chromatography. Second, the Cys336Ser mutant
hould trap a covalent FGE-peptide complex. Third, the
eptide sulfenic acid should be trapped by a modified
ubstrate peptide containing Cys-CF2SH at the posi-
ion of the modified cysteine. Fourth, no oxygen atom
rom O2 but from bulk solvent is incorporated into FGly,
hich could be tested by isotope-labeling experiments.
inally, if molecular oxygen generates the sulfenic acid
y a radical mechanism, radical scavengers should
bolish FGE activity. This last point has been ad-
ressed in initial studies using ibuprofen (1 M–10 mM)
s a radical scavenger. No effect was detected on FGE
ctivity (data not shown), indicating that generation of
he cysteine sulfenic acid does not require radical for-
ation unless the lifetime of the radical involved is too
hort to be efficiently quenched by ibuprofen.
bsence of FGly-Generating Activity in pFGE
hereas all peptides derived from human sulfatases
hat contain an FGly modification motif are converted
y catalytic amounts of FGE, no such activity is ob-
erved with pFGE (Mariappan et al., 2005). The ques-
ion of why pFGE lacks FGly-generating activity can be
irectly answered by the absence of the catalytically
ctive disulfide bond (Figure 1A). However, peptides
hat are substrates for FGE also bind to pFGE (Mariap-
an et al., 2005), because many of the residues (Ala149,
er155, Trp299, Ser333, Ser356, Asn360, and Leu361)
ining the substrate binding groove in FGE are con-
erved in pFGE. This points to the possibility that pFGE
ompetes with FGE for substrates. Indeed, an inhibi-
ory effect of pFGE on FGE-mediated activation of
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549newly synthesized sulfatases has been observed (Mari-
appan et al., 2005). pFGE may exhibit a chaperone-like
function by preserving a pool of unfolded and transla-
tionally arrested sulfatases in the ER for FGE in situa-
tions of increased sulfatase production.
Molecular Basis for Multiple Sulfatase Deficiency
MSD is a rare (52 alleles in 32 patients) autosomal re-
cessive disease. The almost complete lack of all sulfa-
tase activities leads to severe symptoms such as
ataxia; progressive loss of motor abilities, speech, vi-
sion and hearing; hepatosplenomegaly; dystosis multi-
plex; abnormal facies; stiff joints; and ichthyosis, and
ultimately results in untimely death. To determine the
structural reason for MSD, the missense mutations
were mapped onto the FGE crystal structure (Figure 6,
left). A total of 18 missense mutations over 17 different
residues of mature FGE have been found to date, of
which 12 have been published (Cosma et al., 2003;
Cosma et al., 2004; Dierks et al., 2003). Fourteen of
these mutations lead to substitutions of residues that
are strictly conserved among FGE proteins from dif-
ferent organisms. In the remaining three cases (posi-
tions 177, 234, and 279), the residues are highly con-
served as serine or alanine. The mutations fall into three
classes: structure destabilizing, interference with sub-
strate binding, and catalytically inactivating (Supple-
mental Table S2). Most mutations (15 out of 18) destabi-
lize FGE either by inserting a residue with too large a
side chain for efficient packing of the hydrophobic core
or by altering the side chain properties such that impor-
tant interactions are lost (green in Figure 6). Structurally
very interesting are the Pro266Leu and Asn259Ile muta-Figure 6. Molecular Basis of Multiple Sulfatase Deficiency
The known missense multiple sulfatase deficiency (MSD) mutations are mapped onto the FGE structure as spheres and are colored according
to the effect they have on the FGE structure. Green, destabilizing; red, catalytically compromising; yellow, inhibition of substrate binding. The
Ca2+ ions are shown as cyan and magenta spheres. The table compiles a brief structural explanation of the effect the missense mutations
have on the FGE structure. The majority of the mutations will prevent folding of FGE into an active conformation by destabilization of the
hydrophobic core. Further destabilizing mutations are located at a tight surface loop (263 and 266) and at Ca2+-site 1 (259). Mutations marked
with an asterisk, hash mark, and dagger are reported in Cosma et al. (2004), Cosma et al. (2003), and Dierks et al. (2003), respectively. The
S234R and C346W mutations are unpublished (S. Marie and M.F. Vincent, personal communication). All other mutations are our own unpub-
lished data. A more detailed analysis of the effect the mutations have on the FGE structure is presented in Supplemental Table S2.tions, which affect a conserved cis-peptide bond and
Ca2+ binding site 1, respectively. The Asn259Ile muta-
tion supports the notion that the Ca2+ ions strongly
contribute to FGE stability.
Of particular note are the mutations Ala177Pro,
Trp179Ser, and Cys336Arg, which have a more drastic
effect on substrate binding and catalytic activity of
FGE. Ala177 and Trp179 are located close to the active
site, i.e., mutation of these residues will most likely
compromise substrate binding (yellow in Figure 6).
More compellingly, Cys336 is part of the active site and
the Cys336Arg mutation will exhibit a strongly de-
creased, if not complete loss of, catalytic activity (red
in Figure 6), similar to the Cys336Ser mutation (see
above).
Conclusions
The human FGE forms the bottleneck in the activation
of all sulfatases. The structure explains on a molecular
basis the effect of several missense mutations that lead
to MSD. The severity of the disease and the fact that
most of the mutations lead to destabilized, and there-
fore inactive, FGE allows the conclusion that there is
no FGE backup activity in human. This is surprising, as
nematodes and fungi lack FGE but still contain FGly-
based sulfatases (Landgrebe et al., 2003). Hence, an-
other FGly-generating system must be present in these
organisms.
We have determined six individual crystal structures
of FGE, which reveal both dead-end products (sulfonic
acids) that delineate the active site and putative reac-
tion intermediates (sulfenic acid), which allowed con-
struction of a unique oxigenase reaction mechanism
Cell
550not hitherto engaged in any other class of enzymes.
Based on unbiased high-resolution electron density, we
propose a cysteine sulfenic acid as a crucial reaction
intermediate in the catalytic cycle of FGly generation.
To our knowledge, FGE is the first enzyme to use mo-
lecular oxygen as a terminal electron acceptor (J. Peng,
K.v.F., T.D., B.S., A.P.-K., and M.M., unpublished) with-
out requirement of an oxygen-activating cofactor such
as FAD. The structural dissimilarity of FGE to Ero1p and
Erv2p excludes that these ER-localized cysteine oxi-
genases share an analogous mechanism. Further
studies are required to entirely unravel FGly formation
by FGE, especially the role of the sulfenic acid. Be-
cause FGE is easily inactivated by irreversible oxidation
of Cys336 and/or Cys341, the presence of reactive oxy-
gen species in the ER may have prompted evolution of
an FGE-protecting system of which the paralog pFGE
may be a part.
Experimental Procedures
FGE was cloned and produced from HT1080 fibrosarcoma cells in
a glycosylated form as described (Preusser-Kunze et al., 2005). As
extensive crystallization trials with the full-length FGE protein were
unsuccessful, limited proteolysis with elastase was employed. A
mixture of elastase and 9.6 mg/ml FGE (1:1000 w/w) was directly
subjected to crystallization trials at 20°C and yielded irregularly
shaped crystals overnight from 30% PEG4000, 0.1 M Tris/HCl [pH
8.5], 0.2 M MgCl2. Large single crystals were obtained from 20%–
25% PEG4000, 0.1 M Tris/HCl [pH 8.0–9.0], 0.2–0.3 M CaCl2. DTT
(2.5 mM) or cysteine (10–20 mM) or H2O2 (0.5%) were added, com-
bined with incubation times ranging from 1 to 72 days, in order to
generate different redox environments during crystal growth and
aging. SDS-PAGE analysis proved the presence of two fragments
in the crystals. Blotting and sequencing of these fragments estab-
lished that the protease had removed the N-terminal residues up
to Glu73 and residues Ser163-Ala176. All data were collected in-
house at 100K on a MAR345 image plate detector mounted on a
MicroMax 007 generator and reduced with the HKL programs (Ta-
ble 1; Otwinowski and Minor, 1997). This data collection protocol
eliminated any possible radiation damage to the active site cys-
teine residues. The space group is P21212 with unit cell dimensions
a = 61.8 Å, b = 109.6 Å, c = 43.4 Å. The Matthews coefficient (VM =
2.3 Å3/Da) suggested one molecule in the asymmetric unit with a
solvent content of 46%. All structure determination and refinement
calculations were carried out using the CCP4 program suite (CCP4,
1994). The structure was determined from data between 12 Å and
4 Å by molecular replacement with MOLREP using an unrefined
initial model of pFGE (Dickmanns et al., 2005). Rigid body refine-
ment and phase extension to the maximum resolution limit resulted
in readily interpretable maps that allowed manual rebuilding of the
model with O (Jones et al., 1991). All other FGE structures were
determined by molecular replacement using the first FGE structure
as the starting model. Refinement was performed with REFMAC5
with the same set of 5% of reflections reserved for Rfree crossvali-
dation (Brünger, 1992). Water oxygen atoms were assigned auto-
matically with ARP/wARP (Lamzin and Wilson, 1993). In the final
models, residues Ser163-Ala176 are absent as a result of proteoly-
sis. Thirteen N- and three C-terminal residues followed by the se-
quence RGSH6 display poor electron density and are disordered to
various extents depending on the actual crystal. Two metal ions are
present in all structures (Sr2+ in structure 4, Ca2+ in all others). Two
N-acetyl-glucosamine moieties at Asn141 were visible in the
electron density. Two residues, Phe284 and Asn297, have disal-
lowed f/ψ–combinations in the Ramachandran plot, but these resi-
dues display excellent electron density. Phe284 is very close to a
generously allowed region, and Asn297 binds to the Ca2+ ion in site
2. Data collection and refinement statistics are summarized in Table
1. Possible hydrogen bonds, salt bridges, and van der Waals con-
tacts were detected with HBPLUS (McDonald and Thornton, 1994)
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Bnd CONTACSYM (Sheriff et al., 1987) using default parameters.
econdary structure was assigned with STRIDE (Frishman and Ar-
os, 1995). Figure 1A was generated with ESPript (Gouet et al.,
003). Structure figures were created with Bobscript (Esnouf, 1997)
nd rendered with Raster3D (Merritt and Murphy, 1994). Surfaces
ere calculated with PyMol (http://pymol.sourceforge.net/).
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